Literature DB >> 24666437

Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.

D Cárdenas Sierra1, G Vélez Colmenares, A Orfao de Matos, S Fiorentino Gómez, S M Quijano Gómez.   

Abstract

Epstein-Barr virus (EBV) is present in 95% of the world's adult population. The immune response participates in immune vigilance and persistent infection control, and this condition is maintained by both a good quality (functionality) and quantity of specific T cells throughout life. In the present study, we evaluated EBV-specific CD4(+) and CD8(+) T lymphocyte responses in seropositive healthy individuals younger and older than 50 years of age. The assessment comprised the frequency, phenotype, functionality and clonotypic distribution of T lymphocytes. We found that in both age groups a similar EBV-specific T cell response was found, with overlapping numbers of tumour necrosis factor (TNF)-α(+) T lymphocytes (CD4(+) and CD8(+)) within the memory and effector cell compartments, in addition to monofunctional and multi-functional T cells producing interleukin (IL)-2 and/or interferon (IFN)-γ. However, individuals aged more than 50 years showed significantly higher frequencies of IL-2-producing CD4(+) T lymphocytes in association with greater production of soluble IFN-γ, TNF-α and IL-6 than subjects younger than 50 years. A polyclonal T cell receptor (TCR)-variable beta region (Vβ) repertoire exists in both age groups under basal conditions and in response to EBV; the major TCR families found in TNF-α(+) /CD4(+) T lymphocytes were Vβ1, Vβ2, Vβ17 and Vβ22 in both age groups, and the major TCR family in TNF-α(+) /CD8(+) T cells was Vβ13·1 for individuals younger than 50 years and Vβ9 for individuals aged more than 50 years. Our findings suggest that the EBV-specific T cell response (using a polyclonal stimulation model) is distributed throughout several T cell differentiation compartments in an age-independent manner and includes both monofunctional and multi-functional T lymphocytes.
© 2014 British Society for Immunology.

Entities:  

Keywords:  EBV-specific memory and effector T lymphocytes; TCR-Vβ repertoire; flow cytometry; multi-functional T lymphocytes; soluble cytokines

Mesh:

Substances:

Year:  2014        PMID: 24666437      PMCID: PMC4089182          DOI: 10.1111/cei.12337

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  76 in total

1.  Contemporaneous fluctuations in T cell responses to persistent herpes virus infections.

Authors:  Tania Crough; Jacqueline M Burrows; Chrysa Fazou; Susan Walker; Miles P Davenport; Rajiv Khanna
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

2.  Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.

Authors:  Florian Bihl; Nicole Frahm; Loriana Di Giammarino; John Sidney; Mina John; Karina Yusim; Tonia Woodberry; Kaori Sango; Hannah S Hewitt; Leah Henry; Caitlyn H Linde; John V Chisholm; Tauheed M Zaman; Eunice Pae; Simon Mallal; Bruce D Walker; Alessandro Sette; Bette T Korber; David Heckerman; Christian Brander
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

3.  Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.

Authors:  Emanuela M Iancu; Patricia Corthesy; Petra Baumgaertner; Estelle Devevre; Verena Voelter; Pedro Romero; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

Review 4.  EBV the prototypical human tumor virus--just how bad is it?

Authors:  David A Thorley-Lawson
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

5.  Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.

Authors:  Christian Maczek; Thomas G Berger; Beatrice Schuler-Thurner; Erwin S Schultz; Anett Hamann; P Rod Dunbar; Vincenzo Cerundolo; Alexander Steinkasserer; Gerold Schuler
Journal:  Int J Cancer       Date:  2005-06-20       Impact factor: 7.396

Review 6.  Immunosenenescence: role of cytomegalovirus.

Authors:  Graham Pawelec
Journal:  Exp Gerontol       Date:  2013-11-28       Impact factor: 4.032

7.  Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors:  Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

Review 8.  Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity.

Authors:  Martin Rowe; Jianmin Zuo
Journal:  Microbes Infect       Date:  2010-02-01       Impact factor: 2.700

Review 9.  Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

Authors:  Andrew D Hislop; Graham S Taylor; Delphine Sauce; Alan B Rickinson
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

10.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  5 in total

1.  Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

Authors:  D Cárdenas; G Vélez; A Orfao; M V Herrera; J Solano; M Olaya; A M Uribe; C Saavedra; M Duarte; M Rodríguez; M López; S Fiorentino; S Quijano
Journal:  Clin Exp Immunol       Date:  2015-09-11       Impact factor: 4.330

Review 2.  Primary Progressive Multiple Sclerosis: Putting Together the Puzzle.

Authors:  Ahmed Abdelhak; Martin S Weber; Hayrettin Tumani
Journal:  Front Neurol       Date:  2017-05-31       Impact factor: 4.003

Review 3.  How age and infection history shape the antigen-specific CD8+ T-cell repertoire: Implications for vaccination strategies in older adults.

Authors:  Josien Lanfermeijer; José A M Borghans; Debbie van Baarle
Journal:  Aging Cell       Date:  2020-10-20       Impact factor: 9.304

4.  Age and CMV-Infection Jointly Affect the EBV-Specific CD8+ T-Cell Repertoire.

Authors:  Josien Lanfermeijer; Peter C de Greef; Marion Hendriks; Martijn Vos; Josine van Beek; José A M Borghans; Debbie van Baarle
Journal:  Front Aging       Date:  2021-04-29

5.  Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients.

Authors:  Diana M Hernández; Sandra Valderrama; Sandra Gualtero; Catalina Hernández; Marcos López; Maria Victoria Herrera; Julio Solano; Susana Fiorentino; Sandra Quijano
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.